Sugi Predict

Sugi Predict / Compounds / SCHEMBL19933655

SCHEMBL19933655

SCHEMBL19933655

CN(C(=O)c1cc(C(=O)N(C)c2ccc(-c3ccccn3)cc2)cc(-c2ccccc2-c2ccc(-c3cnc(-c4ccc(-c5ccccc5-c5cc(C(=O)N(C)c6ccc(-c7ccccn7)cc6)cc(C(=O)N(C)c6ccc(-c7ccccn7)cc6)c5)cc4)cn3)cc2)c1)c1ccc(-c2ccccn2)cc1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 1/20 0.43
▸ BCR P11274 1/20 0.43
▸ CHEK2 O96017 1/20 0.41
▸ KDM4E B2RXH2 3/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ OXTR P30559 2/20 0.39
▸ TRPV1 Q8NER1 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ ATR Q13535 1/20 0.38
▸ ATM Q13315 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ GFER P55789 1/20 0.37
▸ AVPR1A P37288 1/20 0.37
▸ ALOX5AP P20292 1/20 0.37
▸ FEN1 P39748 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21721909 0.93 ABL1 (0.43) ABL1BCRCHEK2KDM4EKMT2A
SCHEMBL21721929 0.91 CHEK2 (0.42) ABL1BCRCHEK2KDM4EKMT2A
SCHEMBL21125955 0.91 ABL1 (0.45) ABL1BCRCHEK2KDM4EKMT2A
SCHEMBL23018807 0.89 ABL1 (0.36) ABL1BCRCHEK2KDM4EKMT2A
SCHEMBL19933656 0.89 ABL1 (0.45) ABL1BCRCHEK2KDM4EKMT2A
SCHEMBL22059897 0.88 GPBAR1 (0.41) ABL1BCRCHEK2KDM4EKMT2A
SCHEMBL19933690 0.88 NPC1 (0.43) ABL1BCRCHEK2KDM4EKMT2A
SCHEMBL18573166 0.88 ABL1 (0.51) ABL1BCRKDM4EKMT2AOXTR
SCHEMBL19933702 0.88 ABL1 (0.42) ABL1BCRCHEK2KDM4EKMT2A
SCHEMBL21397866 0.84 ABL1 (0.43) ABL1BCRCHEK2KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10889604-B2 Binuclear and trinuclear metal complexes composed of two inter-linked tripodal hexadentate ligands for use in electroluminescent devices MERCK PATENT GMBH 2021-01-12 — — US disclosed
US-20190202851-A1 BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2019-07-04 — — US disclosed
WO-2018041769-A1 BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2018-03-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190202851-A1 BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES PARN, PUF60, PARG ABL1 2444/4885BCR 3740/4885CHEK2 2936/4885
US-10889604-B2 Binuclear and trinuclear metal complexes composed of two inter-linked tripodal hexadentate ligands for use in electroluminescent devices PARN, PUF60, PARG ABL1 2444/4885BCR 3740/4885CHEK2 2936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.